
LSB
LakeShore Biopharma Co Ltd
- Overview
- Forecast
- Valuation
- Earnings

Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
0.850
Open
0.850
VWAP
0.83
Vol
34.58K
Mkt Cap
33.79M
Low
0.8062
Amount
28.64K
EV/EBITDA(TTM)
--
Total Shares
41.21M
EV
86.97M
EV/OCF(TTM)
--
P/S(TTM)
0.19
LakeShore Biopharma Co Ltd, formerly YS Biopharma Co Ltd, is a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer. The Company's vaccine product YSJATM rabies vaccine has been commercialized. The Company also has four product candidates under various clinical development stages, including PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, PIKA YS-ON-001 and PIKA YS-HBV-001, and four preclinical stage product candidates, targeting HBV, influenza and cancer with enormous medical demand. In addition, the Company is working on a series of therapeutic targets, rabies and products at the discovery stage.
Show More
Valuation Metrics
The current forward P/E ratio for LakeShore Biopharma Co Ltd (LSB.O) is 2.15, compared to its 5-year average forward P/E of -1.33. For a more detailed relative valuation and DCF analysis to assess LakeShore Biopharma Co Ltd 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A
5Y Average PE
-1.33
Current PE
2.15
Overvalued PE
0.12
Undervalued PE
-2.77
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A
5Y Average EV/EBITDA
-32.01
Current EV/EBITDA
5.38
Overvalued EV/EBITDA
12.82
Undervalued EV/EBITDA
-76.84
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A
5Y Average PS
0.55
Current PS
0.16
Overvalued PS
1.11
Undervalued PS
-0.01
Financials
Annual
Quarterly
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
LSB News & Events
Events Timeline
2025-08-18 (ET)
2025-08-18
08:04:24
LakeShore Biopharma Gets Non-Binding Acquisition Offer from Oceanpine

2024-12-12 (ET)
2024-12-12
19:00:12
LakeShore Biopharma provides update on ongoing investigation involving Yi Zhang

2024-10-29 (ET)
2024-10-29
08:40:50
LakeShore Biopharma regains ompliance with Nasdaq minimum bid price requirement

Sign Up For More Events
Sign Up For More Events
News
8.5
08-18NASDAQ.COMPinnedLakeShore Biopharma Gets Proposal from Oceanpine Capital
8.5
08-18PRnewswirePinnedLakeShore Biopharma Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company
9.5
07-31NewsfilterLakeShore Biopharma Announces Fiscal Year 2025 Financial Results
Sign Up For More News
People Also Watch

BEDU
Bright Scholar Education Holdings Ltd
1.670
USD
-4.02%

CELU
Celularity Inc
4.150
USD
+19.25%

FBIO
Fortress Biotech Inc
2.250
USD
+6.13%

OPI
Office Properties Income Trust
0.232
USD
-4.54%

NVNI
Nvni Group Ltd
0.594
USD
+4.40%

KSCP
Knightscope Inc
5.810
USD
+4.50%

MDIA
Mediaco Holding Inc
1.300
USD
-0.46%

CLST
Catalyst Bancorp Inc
12.600
USD
0.00%

SSBI
Summit State Bank
11.840
USD
+1.20%
FAQ

What is LakeShore Biopharma Co Ltd (LSB) stock price today?
The current price of LSB is 0.82 USD — it has increased 5.13 % in the last trading day.

What is LakeShore Biopharma Co Ltd (LSB)'s business?

What is the price predicton of LSB Stock?

What is LakeShore Biopharma Co Ltd (LSB)'s revenue for the last quarter?

What is LakeShore Biopharma Co Ltd (LSB)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for LakeShore Biopharma Co Ltd (LSB)'s fundamentals?

How many employees does LakeShore Biopharma Co Ltd (LSB). have?
